Schneyer Mark C.
CIK 0001899977
EVP, Chief Financial Officer
Filings
29
Latest May 5, 2026
Issuers covered
1
Showing
29 of 29
Page 1
Track record
28 of 28 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 28 | 54% | -1.3% | +0.4% | +29.7% | -44.0% |
| 90 days | 23 | 35% | -8.3% | -8.4% | +41.7% | -59.8% |
| 180 days | 23 | 57% | -4.9% | +8.4% | +37.9% | -53.1% |
| 365 days | 20 | 55% | -7.0% | +3.7% | +48.6% | -60.0% |
Issuers
Companies where Schneyer Mark C. has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| ACAD | Acadia Pharmaceuticals Inc | 29 | May 5, 2026 |
All filings
29 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|